Disrupt. Rewire. Heal. The New Clinical Promise of Psychedelics

Psychedelic medicine is moving from the margins to mainstream neuroscience. 🧠✨   A recent Nature Medicine review synthesizes the biology behind the renaissance: 5-HT2A signaling, acute brain desynchronization, and a subacute plasticity window driven by BDNF–TrkB pathways.   The promise is real — rapid effects in depression, PTSD, and addiction — but so are the challenges: expectancy, unblinding, scalability, and safety.   Entropy. Plasticity. Psychiatry. 🔬   A field worth watching — carefully, rigorously, and responsibly.